Celyad Sa (CYAD)

Trade CYAD now with
1/18/2021 1:07:36 AM Celyad Oncology Presents Data Update From Phase 1 AlloSHRINK Trial For CYAD-101 In MCRC At ASCO-GI Symposium
1/7/2021 1:20:56 AM Celyad Oncology Enters Committed Equity Purchase Agreement For Up To $40 Mln With Lincoln Park Capital Fund
12/7/2020 1:12:37 AM Celyad Oncology Says Disappointed By Latest Update From Phase 1 THINK Trial For CYAD-01
9/29/2020 1:03:05 AM Celyad Oncology Enters Clinical Trial Collaboration With Merck
6/10/2020 1:05:46 AM Celyad Changes Name To Celyad Oncology
6/1/2020 1:21:24 AM Celyad Announces Updates From Allogeneic Programs
3/2/2020 1:06:08 AM Celyad Names Stephen Rubino Chief Business Officer
1/13/2020 1:04:22 AM Celyad Doses First Patient With CYAD-02 In CYCLE-1 Trial For R/r AML And MDS
11/29/2019 1:06:05 AM Celyad Says Christian Homsy Steps Down From Board Of As Current CEO Filippo Petti Is Nominated Into The Role
10/2/2019 1:05:48 AM Celyad To Present Update On MCRC Clinical Program At 2019 SITC Annual Meeting
9/12/2019 9:59:02 AM Celyad Prices Offering Of 2 Mln Shares At $10.00/ADS
1/7/2019 1:03:59 AM Celyad Outlines Key 2019 Priorities Including Acceleration Of CYAD-01 Program In R/r AML And MDS